chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pins and needles/tingling in right fingers; Numbness in right fingers; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 01Apr2021 at 13:15 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included liposarcoma (cancer) in right leg in 2007, radiation and surgery to treat liposarcoma in 2007 and preeclampsia during pregnancy in 2017. The patient was allergic to penicillin. Concomitant medications included vitamin d (MANUFACTURER UNKNOWN), prenatal vitamin, probiotic and calcium (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 00:00, the patient experienced needles/tingling/numbness in her right fingers. It was in her middle finger, ring finger and pinkie finger. It went between the entire finger and from the middle knuckle up to the tip. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of the events pins and needles/tingling in right fingers and numbness in right fingers were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
-sore arm & knot @ injection site (day following inj.) -> kept getting larger -> redness a few days after -pt had been to family dr, urgent care, & cardiologist in past 2 months w/ no treatment for arm. ER visit = cellulitis on 12/11 but can't take prescribed abx.
She has shoulder injury related to vaccine administration with decreased range of motion of shoulder, pain at deltoid and pain with overhead activities that persists, albeit some improved, for 2.5  months post vaccination
Presented to the ED for evaluation of cough for the last two weeks. Denies loss of taste or smell, abdominal pain, chest pain, or diarrhea. Reports feeling nauseated but no episodes of emesis. No prior COVID infections.
Pt  was given vaccine, and about 10 minutes, pt passed out. PT was unresponsive for about 60 seconds, breathing strangely. Paramedics were called and pt taken to ER
This spontaneous report was received from a registered nurse and referred to unspecified patients of unknown age and gender. On unknown dates in August 2017 (reported as since 02-AUG-2017), the patients were vaccinated with improperly stored doses of VARIVAX (doses, routes of administration, lot# and expiration date were unknown). The VARIVAX was reconstituted with sterile diluent. No adverse effects were reported. The digital data logger was involved in recording the excursion. The excursion lasted 1 hour and 5 minutes. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1708USA010885.
About I experienced headaches and no fever in 24 hours following my first dose of the Moderna COVID19 vaccine, but about 48 hours later I experienced pain and itchiness with no rash on the soles of both feet and the palms of both hands. This pain and itchiness did lessen in intensity over time, but it has never gone away. I am also experiencing itchiness without a rash all over the skin of my body, including my vagina. When I scratch, red marks rise up on the skin and remain far longer than what is typical for my body. Areas of my body that itch include scalp, inside eyelids, lips, inside ears, outside ears, neck, between breasts, back, stomach, buttocks, thighs, legs, and especially my ankles and the tops of my feet.  The itchiness travels and I have learned to resist the urge to scratch. I went to see my physician for the first time yesterday since the sensation has not abated. I did take my second vaccine on schedule on March 26th (Moderna COVID-19 vaccine, Lot Number 038A21A.). I experienced headaches and a fever of 101F starting about 12 hours after the shot that lasted for 24 hours. The itchiness did not intensify, but it has also not abated.
Dizziness, confusion, nausea, soreness in shoulders minutes after given shot. Next day numbness in feet and calves. Numbness continued up to waist. Always tired. Overcome by weakness when sent to school.
This spontaneous report as received from a registered nurse who read a life story of a patient of unknown age on a website. On an unknown date the patient was vaccinated with GARDASIL (dose, lot no and route not reported). On an unknown date the patient experienced musculoskeletal disorders after vaccination. The outcome of musculoskeletal disorders was unknown. This is one of several reports received from the same source. Additional information is not expected.
Pt reported extreme itching all over his body starting 2 days after receiving the vaccine. He does not have a PCP and presented to the student clinic twice and was given samples of diphenhydramine and urged to seek immediate med treatment since we are a student only clinic. Pt did not seek care but reported to me by phone that Benadryl helped the itching which only subsided one month after it began.
Local board of health nurse administered 0.25 FLULVAL Quadrivalent vaccine to a 2 year old patient. (Vaccine licensed for 3 and older). She contacted the State Department of Public Health, who let her know that most likely the patient would need to be contacted revaccinated. The Local Board of Health nurse stated there were no adverse events noted in the patient. The nurse at the State DPH contacted GSK to ensure that this was indeed the case. A pharmacist at GSK stated that they do not have any data on the 0.25 dose, only on 0.5 dose and that they had recently filed papers to extend the age limit down to 6 months on FLULAVAL, but using a 0.5 dose. The GSK pharmacist confirmed that this patient should be revaccinated with the correct flu vaccine for her age. This was communicated to the Local Board of health nurse by the State DPH nurse.
Patient received 0.5 cc Fluarix vaccination IM; this is not approved by the FDA for use in children younger than 18 years.  No apparent side effects.
Auscultation done post injection. Slight bilateral wheezes decreased lobes. Pt denies difficulty breathing. No nasal flare observed. No angioedema observed. No rash  - EMS called breathing treatment administered by EMS 11:10 am transferred to hospital and parent left with EMS 11;26 a.m.
nausea x 2 days, with severe pain and mild swelling injection site (right deltoid) pain radiating down right arm to hand, numbness and weakness right 4th & 5th fingers, right neck pain radiating up to b/l temples, severe migraines, generalized myalgias, weakness and fatigue
Patient received tetanus in left deltoid on 05/03/04.  Stated has had continued pain and swelling in arm since vaccination.  Redness with warmth noted inside of left arm and swollen lymph gland in left axilla.  Dneies fever.  No known history of allergy to tetanus.
PULMONARY EMBOLISM; This spontaneous report received from a consumer via a company representative concerned a 63 year old male, race and ethnicity unspecified. The patient's height, and weight were not reported. The patient's medical history was not reported. The patient was very healthy, athletic and a marathon runner.   The patient's mother died last year of an aneurysm.  The patient's dad is in his 80's is very healthy.   The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination.  The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the subject developed pulmonary embolism causing death six days after receiving the vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on an unspecified date.   This report was serious (Death).; Sender's Comments: V0: 20210533144-covid-19 vaccine ad26.cov2.s- This case concerns to a 63 year old male. Pulmonary embolism. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: PULMONARY EMBOLISM
Patient called the day after getting the vaccine stating his back is itchy and full of hives and he is short of breath.
Patient stated he saw stars right after shot given for 1 second then went away and he was ok.
Even though I am 49, I am not in perimenopause, I have had a regular period ( and my period begins on the same day within hours of my teenage daughter) forever. I have never had an irregular period in my life, not ever and I started my period nearly 2 weeks early and it was heavy and bright red. It only lasted a few days but I am sure it has everything to do with the vaccine.
Fever 102.5, local rxn of erythema, induration. Rx Motrin, Tylenol.
administered supported TE for PEDVAX HIB and VAXNEUVANCE; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported.  On 02-NOV-2023, the patient was vaccinated with improperly stored doses (product storage error) of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, single dose, lot # reported and confirmed as: X002099, expiration date reported and confirmed as: 14-JUN-2025 (exact dose, site and route of administration were not provided); and pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) in pre-filled syringe, single dose, lot # reported and confirmed as: X005583, expiration date reported and confirmed as: 10-DEC-2024 (exact dose, site and route of administration were not provided). Both vaccines were administered for prophylaxis by a health professional. Temperature excursion details: 33.9 degree Fahrenheit for 42 hours 5 minutes, no previous excursions.  This is one of two reports received from the same reporter. ; Sender's Comments:  US-009507513-2311USA002025:Associated AE Cases: 02503187 // 02503225
Red  and swollen left anterior thigh that is warm to touch with a temperature of 38.1C (rectal). Treated with Keflex for 10 days.
felt bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt bad) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04b21a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included centrum, vitamin D, ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced FEELING ABNORMAL (felt bad). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (felt bad) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-127450 (Patient Link).
10-15min p/vax felt faint; lay down on floor school nurse gave orange juice; brought to vax site-lay down on cot; BS BP 88/60 lying down, P50 strong & regular;
On the evening of 10/21/22 I developed upper respiratory symptoms (nasal drainage, sneezing) that progressed into further symptoms on 10/22 including fever with temperature up to 102F, sore throat and coughing. At home test on 10/23 was positive for COVID-19.  Consulted electronically with my PCP on 10/24 who prescribed Paxlovid. Symptoms are improving as of the evening of 10/25, fever is in the 98-99F range and main ongoing complaint is some moderate nausea. In the days between the vaccination I had three medical appointments, two physical therapy visits and a MRI of my lumbar spine (masked during all activities). COVID diagnosis may be unrelated to my recent vaccination but I was encouraged to report after I noted my symptoms in a V-Safe report.
This spontaneous report as received from a pharmacist refers to female patient who in her seventies with no known allergies. The patient's medical history included shingles. On 13-SEP-2013 the patient ws vaccinated with ZOSTAVAX vial 0.65 ml once, subcutaneously. The patient was feeling "tingling" at an unspecified time on 13-SEP-2013 and reported an outbreak of shingles on 14-SEP-2013. The patient contacted unspecified physician and also contacted pharmacy about outbreak. The patient was prescribed valacyclovir and Zovirax cream which started on 14-SEP-2013. None lab diagnostics studies performed. When patient had shingles prior, acyclovir was prescribed. Pharmacist stated patient was "doing better since she's received treatment". Additional information has been requested.
I developed a lump in my lower neck on the right, not far above the collar bone. I believe it to be a swollen Lymph node but I feel as though it isn't going away
This is a prospective pregnancy case. This female subject was enrolled in a study. The subject received Flu Seasonal QIV on 12th August 2015. Previously administered products included FLUARIX (trivalent received in the past and the patient did not experience any problems). In August 2015, less than a week after receiving Flu Seasonal QIV, the subject developed nausea (Non-serious). Additional event(s) included general body pain in August 2015 and vaccine exposure during pregnancy. The outcome of nausea was unknown. The outcome(s) of the additional event(s) included general body pain (unknown) and vaccine exposure during pregnancy (unknown). The pregnancy was ongoing. It was unknown if the investigator considered the nausea and general body pain to be related to Flu Seasonal QIV. Additional details were provided as follows: On Wednesday, 12th August 2015, the patient received FLUARIX while she was pregnant. In August 2015, less than a week after receiving FLUARIX, the patient experience nausea and body aches (general body pain). The patient seemed to suggest that she received the FLUARIX quadrivalent instead of the trivalent like in years but this could not be clarified. The patient was wondering if the events were normal or not. The caller was from a pharmacy but it was unknown whether she was a pharmacist or technician. The call was dropped before additional details could be gathered, including the contact information.
I do not know which kind of injected influenza vaccine (inactivated or recombinant) it was. I have decreasing soreness at the injection site. In the middle of the night, I woke up in bed, rolled over, and felt vertigo. The dizziness (feeling of spinning or losing balance) continued when I woke up in the morning, and comes and goes as I lean over or move. It is kind of mild. I have not fallen over, but there were a couple times I took a stumbling step to catch my balance.
Patient reported having a rash on her chest. Patient received diphenhydramine 25 mg PO. At 12:12pm patient reported feeling better; symptoms unchanged. At 12:25pm patient reported feeling well; no worsening symptoms. Patient wanted to go home.
post vaccine day 8 developed hives that increasingly got worse through day 10. Day 10 consulted a physician who prescribed prednisone.
red raised rash around the site; red raised rash around the site; This case was reported by a physician via call center representative and described the occurrence of injection site rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In June 2019, the patient received Shingrix. In June 2019, several days after receiving Shingrix, the patient experienced injection site rash and injection site erythema. On an unknown date, the outcome of the injection site rash and injection site erythema were unknown.   It was unknown if the reporter considered the injection site rash and injection site erythema to be related to Shingrix.  Additional details were received as follows: The age vaccination was not reported.  The age group was not reported but was captured as adult as per vaccine indication. The physician reported that had a patient who received  the vaccine and developed red raised rash around the site. The reporter did not consent to follow up. The reporter did not have additional information.
Patient was taken to the ER by his wife, on 4/12/21 with shortness of breath.  He was sent home on continuous O2, which was never needed prior to his vaccination.  Wife denies any chronic health conditions and reports that pt has been to more that one specialist because of his continued need to be on O2.  She reports his saturation drops with minimal exertion and that the client has not even been able to return to work.  When asked what the doctors had said, she reported that they blamed it on his weight.  She reports that his weight has been the same since well before the vaccination.
Patient has MS and UC - weeks of lethargy; Patient has MS and UC - weeks of lethargy; lethargy; This is a spontaneous report from a contactable consumer. A 49-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on Feb2021 01:00 PM at single dose for COVID-19 immunisation.  Medical history included COVID-19 prior vaccination. The patient's concomitant medications were not reported. The patient was not pregnant. Patient has MS (multiple sclerosis) and UC (ulcerative colitis) - weeks of lethargy on Feb2021. AE resulted in doctor or other healthcare professional office/clinic visit. Unknown if treatment received. The patient underwent lab tests and procedures which included SARS-CoV-2 test: COVID yes prior vaccination. Events outcome was recovering.  Information about lot/batch number has been requested.
persistent double vision, starting on May 31, after PPV & Shingles vaccination on May 23.  7/4/08 Reviewed hospital medical records of 5/31-6/1/2008 FINAL DX: acute left 6th nerve palsy Records reveal patient experienced sudden onset double vision.  Had mild HA x 2 wks prior along w/intermittent hearing disturbances.  Had pre-existing intermittent hand numbness unchanged.  Cardio & Neuro consults obtained. Follow-up: Not 100% recovered. Slight visual misalignment (vertical).
I normally have Psoriasis that had been under control and mostly under control before I got the shot. I started to notice a new rash about two days after the shot. My Psoriasis would normally show up as white patches, but these are red bumps. They are more like little red bumps. They are on my arms, sides and hips.  They are a little itchy especially on my back They are still are still there, but they don?t seem to be getting any worse.
Child was inadvertently given the Pfizer 5-11 bivalent booster at 0.2ml dose.  At her age she should have gotten Pfizer 12+ Bivalent booster.  Multiple members of family getting covid booster.  Both parents made aware of error.  Patient had no adverse reaction, received incorrect product/dose for booster.   No guidance from Pfizer given other than information provided through Pfizer (12/9/22)  Contacted parent to relay information, no return call or reply.
Information has been received from an office manager concerning a male patient who was vaccinated with a dose of Pneumovax 23 (lot #651321/1036P). Subsequently, on 13-JUL-2006, the patient experienced red, swollen arm with numbness in palm of hand. The patient saw a physician. The physician sent him to the emergency room but he was not seen right away so he returned back to the physician's office. The physician requested a lot check. Unspecified medical attention was sought. The physician requested a lot check. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met the requirements of Center for Biologics Evaluation and Research and was released. Additional information has been requested.
LEFT ARM PAIN; ALL OVER MUSCLE PAIN; CHILLS; NAUSEA; TOOK A WHILE TO FALL ASLEEP; SAW FACES AND ANIMALS 2 HOURS  POST IMMUNIZATION; MILD CHEST PAIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805022, expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced all over muscle pain. On 10-MAR-2021, the subject experienced chills. On 10-MAR-2021, the subject experienced nausea. On 10-MAR-2021, the subject experienced took a while to fall asleep. On 10-MAR-2021, the subject experienced saw faces and animals 2 hours post immunization. On 10-MAR-2021, the subject experienced mild chest pain. On an unspecified date, the subject experienced left arm pain. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from took a while to fall asleep, and saw faces and animals 2 hours post immunization on 10-MAR-2021, and left arm pain, and had not recovered from all over muscle pain, chills, nausea, and mild chest pain. This report was non-serious.
Patient received 2nd dose of Pfizer COVID vaccine at approx. 10:20am.  At approx. 10:30am the patient passed out and hit the floor.  She was rolled into the recovery position and within a few seconds regained consciousness.  She sat up and I had her stay sitting on the floor with her back against the wall.  911 was called and the fire department arrived in a few minutes and took over evaluating her.
body aches, chills, and stomach ache, fatigue, headache, nausea, mild voice loss, mouth sweats, ear-ache, red eyes, swollen lymph
reconstituted with expired powder portion and gave it to patient; reconstituted with expired powder portion and gave it to patient; reconstituted with expired powder portion and gave it to patient; This case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 53-year-old male patient who received Herpes zoster (Shingrix) (batch number 3R774, expiry date 8th March 2022) for prophylaxis.   On 18th April 2022, the patient received the 2nd dose of Shingrix. On 18th April 2022, unknown after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered, inappropriate preparation of medication and expired vaccine used. On an unknown date, the outcome of the inappropriate dose of vaccine administered, inappropriate preparation of medication and expired vaccine used were unknown.       Additional Information: GSK Receipt Date: 18-APR-2022 Reporter's Comments: The registered nurse called on behalf another health care professional from the facility who reconstituted Shingrix with expired powder portion and gave it to a patient. Only powder portion of Shingrix was expired the diluent portion was not expired. The reporter consented to follow up. Additional Supportive Information: The patient received expired powder portion with diluent which led to inappropriate dose of vaccine administered, inappropriate preparation of medication and expired vaccine used.
Patient reported she was feeling thick in her throat, indicated it felt funny at 3pm, approx. 4 hrs after receiving flu shot. Also noted slight chest tightness. Both resolved with 50 mg BENADRYL. She developed T, achyness and redness which persisted for 24 hours.
Rash (raised and red but not itchy) started on leg in AM of 6/29  but has spread over legs, buttocks' and chest on 6/30.